Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial

Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new 'Revision: v3.5.4' entry was added to the record history, replacing the previous version tag. This update reflects a minor change to the page's versioning metadata rather than substantive content.
    Difference
    0.1%
    Check dated 2026-05-15T23:54:41.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s displayed application/release revision updated from v3.5.2 to v3.5.3, indicating a minor site software/version update rather than a change to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-24T16:55:01.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added revision v3.5.2 to the history and removed revision v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:36:14.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The history log now shows an addition of Revision v3.5.0 and a deletion of Revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-19T19:39:40.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added Study Status and Recruitment Status entries, including Terminated and Sponsor decision dated 2026-02-23 and 2026-02-20. The previous 'Active, not recruiting' status from 2024-08-01 was removed.
    Difference
    0.8%
    Check dated 2026-02-26T14:50:24.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added revision v3.4.2 to the record history and removed v3.4.1. These are minor maintenance changes that do not affect study data or user-facing content.
    Difference
    0.1%
    Check dated 2026-02-12T02:50:40.000Z thumbnail image

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.